Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy
NCT05597280
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
124000
Enrollment
OTHER
Sponsor class
Conditions
Leprosy
Interventions
DRUG:
BE-PEP Bedaquiline
DRUG:
SDR-PEP Rifampicin
DRUG:
BE-PEP Rifampicin
Sponsor
Institute of Tropical Medicine, Belgium